This invention provides a method for extracting active ingredients from *
Erigeron breviscapus*, belonging to the field of
pharmaceutical technology. Based on the differences in the physicochemical properties of the compounds, this invention first achieves preliminary separation of
caffeic acid esters and
scutellarin, followed by further purification and separation based on the properties of the two types of substances. Specifically, this invention uses
ethanol-water solutions of different concentrations to extract
caffeic acid esters stepwise, and uses macroporous and microporous resins for preliminary separation of the
caffeic acid esters.
Scutellarin is then preliminarily separated through acid-base treatment. Finally, high-purity
scutellarin, 3,5-
dicaffeoylquinic acid, 3,4-
dicaffeoylquinic acid, 4,5-
dicaffeoylquinic acid, and
scutellarin are obtained through reversed-phase industrial
chromatography. This invention achieves the extraction and separation of multiple active ingredients from *
Erigeron breviscapus*, and all solvents used in the extraction and
separation process are recyclable, resulting in low cost.